Key result
Insulin-only regimens are linked to poorest glycemic control at ~15% compared with other therapies.
Cross-Sectional (n=827)
Answers are grounded in this paper and cite their sources.
Control of glycemia and other risk factors in people with diabetes has a critical bearing on clinical outcome. Using data from the US National Health and Nutrition Examination Survey 1999-2002, the authors compared the characteristics and control among diabetic subjects in different antidiabetic treatment groups. Among diagnosed diabetic subjects (n=827), 18.3%, 15.2%, 56.6%, and 9.6% used diet therapy alone, insulin therapy alone, oral antidiabetic drugs alone, or both insulin and oral antidiabetic drugs, respectively. The pattern of antidiabetic treatment differed by age and race/ethnicity, but not sex and status of the cardiometabolic syndrome. Only a minority of patients had satisfactory control of glycemia (38.8%), low-density lipoprotein cholesterol (35.0%), and blood pressure (42.5%). Patients taking only insulin had the poorest glycemic control (15.2%), while patients using diet treatment alone (65.9%) had the best glycemic control. There is a need to improve glycemic control. Better patient education, intensive lifestyle changes, and newer therapies need to be explored.
No takes yet. Share an insight, caveat, or question.
Ong et al. (2006) conducted a cross-sectional in Diabetes Mellitus (n=827). Different antidiabetic treatment groups vs. Across treatment groups was evaluated on Satisfactory control of glycemia, low-density lipoprotein cholesterol, and blood pressure. Different antidiabetic treatment regimens were associated with varying glycemic control, which was poorest in insulin-only users and best in diet-only users.
Synapse has enriched 10 related papers. Consider them for comparative context: